NOELIA CILLI: Open Payments
NPI 1417360249 · ELMHURST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,080 in 79 payments from 17 companies in 2025. Trend: 2023 $3,533 · 2024 $3,501 · 2025 $2,080
Food & beverage: $1,993Education: $88
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 7 | $249 |
| Janssen Biotech, Inc. | 10 | $229 |
| Novartis Pharmaceuticals Corporation | 7 | $204 |
| UCB, Inc. | 5 | $196 |
| Regeneron Healthcare Solutions, Inc. | 5 | $173 |
| Incyte Corporation | 9 | $161 |
| PFIZER INC. | 8 | $159 |
| GENZYME CORPORATION | 5 | $158 |
| ABBVIE INC. | 6 | $153 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $105 |
Products named: DUPIXENT, TREMFYA, Bimzelx, COSENTYX, OPZELURA, NEMLUVIO, ILUMYA, RINVOQ.
Industry payments across NY — which companies pay providers there.
